Revolution Stalled
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Drug discovery is at a near standstill for psychiatric disorders such as schizophrenia, bipolar disorder, and depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Self-citationOptogenetics in neural systems
Yizhar, O., Fenno, L. E., Davidson, T. J., Mogri, M., & Deisseroth, K. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.004 · Cited by 1,881
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Genetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Research works printed but not linked: 4
- E. J. Nestler S. E. Hyman R. J. Malenka Molecular Neuropharmacology: Foundation for Clinical Neuroscience (McGraw Hill New York 2009).
- National Center for Biotechnology Information of the US National Library of Medicine www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed. Consulted 25 August 2012.
- T. S. Kuhn The Structure of Scientific Revolutions (Univ. Chicago Press Chicago ed. 2 1962).
- D. J. Carlat Unhinged: The Trouble with Psychiatry (Free Press New York 2010).
Cited by
Items 101–200 of 276
Litten, R. Z., Falk, D. E., Ryan, M. L., Fertig, J. B., & Leggio, L. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14233 · Cited by 31
Selection of Models: Evolution and the Choice of Species for Translational Research
Bolker, J. A. (2019) · Brain Behavior and Evolution · doi:10.1159/000500317 · Cited by 32
Jacobsen, J. P. R., Oh, A., Bangle, R. E., Roberts, W. L., Royer, E. L., Modesto, N., Windermere, S. A., Yi, Z., Vernon, R. L., Cajina, M., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0400-1 · Cited by 30
Biomarkers and neurobehavioral diagnosis
Ewen, J. B., Potter, W. Z., & Sweeney, J. A. (2021) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100029 · Cited by 32
Models of neuromodulation for computational psychiatry
Iglesias, S., Tomiello, S., Schneebeli, M., & Stephan, K. E. (2017) · WIREs Cognitive Science · doi:10.1002/wcs.1420 · Cited by 26
Neuroessentialism: Theoretical and Clinical Considerations
Schultz, W. (2015) · Journal of Humanistic Psychology · doi:10.1177/0022167815617296 · Cited by 32
The complex affective and cognitive capacities of rats
Bartal, I. B.-A. (2024) · Science · doi:10.1126/science.adq6217 · Cited by 28
Back to basics: luring industry back into neuroscience
Hyman, S. E. (2016) · Nature Neuroscience · doi:10.1038/nn.4429 · Cited by 27
Self-citationBranchi, I. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104678 · Cited by 31
Kang, J. H., & Ko, Y. T. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10424 · Cited by 32
Improving Translation by Identifying Evidence for More Human-Relevant Preclinical Strategies
Ritskes-Hoitinga, M. J., Leenaars, C. H. C., Beumer, W., Roo, T. C.-D., Stafleu, F. R., & Meijboom, F. L. B. (2020) · Animals · doi:10.3390/ani10071170 · Cited by 29
Human genome–guided identification of memory-modulating drugs
Papassotiropoulos, A., Gerhards, C., Heck, A., Ackermann, S., Aerni, A., Schicktanz, N., Auschra, B., Demougin, P., Mumme, E., Elbert, T. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314478110 · Cited by 29
de Jong, S., Vidler, L. R., Mokrab, Y., Collier, D. A., & Breen, G. D. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116653109 · Cited by 26
What the alcohol doctor ordered from the neuroscientist
Heilig, M., & Leggio, L. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2015.07.023 · Cited by 25
Closed-Loop Rehabilitation of Age-Related Cognitive Disorders
Mishra, J., & Gazzaley, A. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1396011 · Cited by 24
The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When?
Posner, J. E. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.07.874 · Cited by 27
Redirecting the revolution: new developments in drug development for psychiatry
Brady, L. S., Potter, W. Z., & Gordon, J. A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1666102 · Cited by 25
MacEwan, J. P., Seabury, S. A., Aigbogun, M. S., Kamat, S., van Eijndhoven, E. A., François, C., Henderson, C., & Citrome, L. (2016) · PubMed · Cited by 24
Wang, L., Xia, Y., Chen, Y., Dai, R., Qiu, W., Meng, Q., Kuney, L., & Chen, C. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.02.002 · Cited by 24
The neuroscience of mental illness: Building toward the future
Gordon, J. A., Dzirasa, K., & Petzschner, F. H. (2024) · Cell · doi:10.1016/j.cell.2024.09.028 · Cited by 24
The Breivik case and “conditio psychiatrica”
Parnas, J. (2013) · World Psychiatry · doi:10.1002/wps.20003 · Cited by 22
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
Reay, W. R., Geaghan, M. P., Atkins, J., Carr, V. J., Green, M. J., & Cairns, M. J. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.07.011 · Cited by 24
Human in vitro systems for examining synaptic function and plasticity in the brain
Lee, K., Park, T., Heppner, P. A., Schweder, P. M., Mee, E. W., Dragunow, M., & Montgomery, J. M. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00411.2019 · Cited by 22
Pathways to new drug discovery in neuropsychiatry
Berk, M. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-151 · Cited by 22
Know Thyself: Well-Being and Subjective Experience.
LeDoux, J. E., Brown, R., Pine, D. S., & Hofmann, S. G. (2018) · PubMed Central · Cited by 27
Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology
Grabb, M. C., & Gobburu, J. V. S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.003 · Cited by 22
Naim, R., Kircanski, K., Gold, A. L., German, R. E., Davis, M., Perlstein, S., Clayton, M., Revzina, O., & Brotman, M. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-039169 · Cited by 22
Neural stem cells as tools for drug discovery: novel platforms and approaches
Gorba, T., & Conti, L. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.805199 · Cited by 21
Neurobiology: learning from marmosets
Marx, V. (2016) · Nature Methods · doi:10.1038/nmeth.4036 · Cited by 20
Investigación traslacional en psiquiatría: el marco Research Domain Criteria (RDoC)
Vilar, A., Pérez, V., Blasco, M. J., Pérez-Gallo, E., Ballester, L., Vila, S., Alonso, J., Serrano‐Blanco, A., & Forero, C. G. (2018) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.04.002 · Cited by 23
The Importance of Common Currency Tasks in Translational Psychiatry
Pike, A. C., Lowther, M., & Robinson, O. J. (2021) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-021-00225-w · Cited by 22
The Unconscionable Gap Between What We Know and What We Do
Hyman, S. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010312 · Cited by 18
Self-citationOña, G., & Bouso, J. C. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191212103330 · Cited by 19
Turck, C. W., & Filiou, M. D. (2015) · Complex Psychiatry · doi:10.1159/000381902 · Cited by 20
Abram, S. V., Coster, L. D., Roach, B. J., Mueller, B. A., van Erp, T. G. M., Calhoun, V. D., Preda, A., Lim, K. O., Turner, J. A., Ford, J. M., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz091 · Cited by 18
A Molecular Landscape of Mouse Hippocampal Neuromodulation
Smith, S. J., & von Zastrow, M. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.836930 · Cited by 15
Translational research in psychiatry: The Research Domain Criteria Project (RDoC)
Vilar, A., Pérez, V., Blasco, M. J., Pérez-Gallo, E., Ballester, L., Vila, S., Alonso, J., Serrano‐Blanco, A., & Forero, C. G. (2019) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.04.002 · Cited by 17
Ibrahim, I. M. A., Tobar, S., Fathi, W., Elsayed, H. M., Yassein, A., Eissa, A., Elsheshtawy, E., Elboraei, H., Shahda, M., Elwasify, M., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.011 · Cited by 19
Lear, A., Baker, S. N., Clarke, H. F., Roberts, A., Schmid, M. C., & Jarrett, W. (2022) · Current Research in Neurobiology · doi:10.1016/j.crneur.2022.100049 · Cited by 19
Proceedings of a workshop to address animal methods bias in scientific publishing
Krebs, C. E., Camp, C., Constantino, H., Courtot, L., Kavanagh, O., Leite, S. B., Madden, J., Paini, A., Poojary, B., Tripodi, I. J., et al. (2022) · ALTEX · doi:10.14573/altex.2210211 · Cited by 17
Translating Neurogenomics Into New Medicines
Wendland, J. R., & Ehlers, M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.027 · Cited by 17
Nam, K. H., Yi, S. A., Jang, H. J., Han, J., & Lee, J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01260-z · Cited by 18
Sánchez, S. M., Tsuchiyagaito, A., Kuplicki, R., Park, H., Postolski, I., Rohan, M. L., Paulus, M. P., & Guinjoan, S. M. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.012 · Cited by 17
Public–private partnerships to revitalize psychiatric drug discovery
Brady, L. S., & Potter, W. Z. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.867944 · Cited by 16
Pharmaceutical Innovation Gets a Little Help from New Friends
Munos, B. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005281 · Cited by 16
The biology of mental disorders: progress at last
Hyman, S. E. (2023) · Daedalus · doi:10.1162/daed_a_02038 · Cited by 15
Self-citationJaljuli, I., Kafkafi, N., Giladi, E., Golani, I., Gozes, I., Chesler, E. J., Bogue, M. A., & Benjamini, Y. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002082 · Cited by 15
Clementz, B. A., Chattopadhyay, I., Trotti, R. L., Parker, D., Gershon, E. S., Hill, S. K., Ivleva, E. I., Keedy, S., Keshavan, M. S., McDowell, J. E., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.006 · Cited by 17
In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology
Huang, L., Merson, T. D., & Bourne, J. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.009 · Cited by 16
The Use of Mixed Methods in Drug Discovery
Berk, M., Otmar, R., Dean, O. M., Berk, L., & Michalak, E. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00006-3 · Cited by 17
Drug discovery in psychopharmacology: from 2D models to cerebral organoids
Rossetti, A. C., Koch, P., & Ladewig, J. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.2/jladewig · Cited by 15
Future Viable Models of Psychiatry Drug Discovery in Pharma
Rizzo, S. J. S., Edgerton, J. R., Hughes, Z. A., & Brandon, N. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113475871 · Cited by 14
Nicholson, J. R., & Sommer, B. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818804030 · Cited by 15
Challenges in the Relationships between Psychological and Biological Phenomena in Psychopathology
Miller, G. A., & Bartholomew, M. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108750349.022 · Cited by 16
Vlaikou, A., Nußbaumer, M., Komini, C., Lambrianidou, A., Konidaris, C., Trangas, T. T., & Filiou, M. D. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15057 · Cited by 14
Systematic Reviews of Animal Studies
Athalye‐Jape, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-71921-0_17 · Cited by 13
Allen, S. J., & Morishita, H. (2024) · Science Advances · doi:10.1126/sciadv.adh3920 · Cited by 15
Zebrafish uncover novel antipsychotics
Leung, L. C., & Mourrain, P. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2114 · Cited by 13
Precision medicine for psychosis: a revolution at the interface of psychiatry and neurology
Keshavan, M. S., & Clementz, B. A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00788-0 · Cited by 13
Frau, R., & Bortolato, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.013 · Cited by 13
Circadian rhythms and mood: Opportunities for multi‐level analyses in genomics and neuroscience
Li, J. Z. (2013) · BioEssays · doi:10.1002/bies.201300141 · Cited by 15
Translational psychiatry—light at the end of the tunnel
Jones, K., Menniti, F. S., & Sivarao, D. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12725 · Cited by 16
Targeting Functional Biomarkers in Schizophrenia with Neuroimaging
Wylie, K. P., Smucny, J., Legget, K. T., & Tregellas, J. R. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160127113912 · Cited by 15
Natale, N. R., Kent, M., Fox, N. S., Vavra, D. T., & Lambert, K. G. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.10.004 · Cited by 13
Fernández, N. M., Rainieri, S., Olivas, R. M., Oro‐Carretero, P. D., & Sanz-Landaluze, J. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03486-2 · Cited by 12
The Potential Impact of Selected Bacterial Strains on the Stress Response
Anker-Ladefoged, C., Langkamp, T., & Mueller‐Alcazar, A. (2021) · Healthcare · doi:10.3390/healthcare9050494 · Cited by 12
Yakimov, V., Moussiopoulou, J., Roell, L., Kallweit, M. S., Boudriot, E., Mortazavi, M., Papiol, S., Krčmář, L., Campana, M., Schulte, E. C., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00543-4 · Cited by 13
Hsu, Y.-H. H., Pintacuda, G., Liu, R., Nacu, E., Kim, A., Tsafou, K., Petrossian, N., Crotty, W. J., Suh, J. M., Riseman, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106701 · Cited by 14
Lemke, J. R., Eoli, A., Krey, I., Popp, B., Strehlow, V., Wittekind, D. A., Vuorinen, A., Aldhalaan, H., Baer, S., Martin, A. D. S., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03279-4 · Cited by 15
Grezenko, H., Rodoshi, Z. N., Mimms, C. S., Ahmed, M., Sabani, A., Hlaing, M. S., Batu, B. J., Hundesa, M. I., Ayalew, B. D., Shehryar, A., et al. (2024) · Cureus · doi:10.7759/cureus.58776 · Cited by 12
Guinjoan, S. M., Bär, K., & Camprodon, J. A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.026 · Cited by 11
Uthayathas, S., Shaffer, C. L., Menniti, F. S., Schmidt, C. J., & Papa, S. M. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.02.004 · Cited by 10
Doyle, A. E., Bearden, C. E., Gur, R. E., Ledbetter, D. H., Martin, C. L., McCoy, T. H., Paşaniuc, B., Perlis, R. H., Smoller, J. W., & Davis, L. K. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.10.006 · Cited by 11
Neural Circuits of Fear and Anxiety: Insights from a Neuroethological Perspective
Melleu, F. F., & Canteras, N. S. (2024) · Physiology · doi:10.1152/physiol.00042.2024 · Cited by 10
The place of psychotherapy in contemporary psychiatry.
Tavakoli, S. (2014) · PubMed Central · Cited by 9
The mGluR Theory of Fragile X: From Mice to Men
Stoppel, L. J., Osterweil, E. K., & Bear, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00009-3 · Cited by 14
Doyle, A. E. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12401 · Cited by 9
Genome‐wide association study of lymphoblast cell viability after clozapine exposure
de With, S. A. J., Pulit, S. L., Wang, T., Staal, W., van Solinge, W. W., de Bakker, P. I. W., & Ophoff, R. A. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32287 · Cited by 8
The need for advanced three-dimensional neural models and developing enabling technologies
Merryweather, D. J., & Roach, P. (2017) · MRS Communications · doi:10.1557/mrc.2017.50 · Cited by 9
Kalaria, S. N., McElroy, S. L., Gobburu, J. V. S., & Gopalakrishnan, M. (2019) · Clinical and Translational Science · doi:10.1111/cts.12682 · Cited by 9
Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?Preprint
Oña, G., & Bouso, J. C. (2019) · Preprints.org · doi:10.20944/preprints201901.0249.v1 · Cited by 8
Consideration of genetic and sex effects in mice enhances consilience with human addiction studiesPreprint
Saul, M. C., Bagley, J. R., Bailey, L. S., Datta, U., Dickson, P. E., Dodd, R., Gagnon, L. H., Huggett, S. B., Kimble, V. M., Leonardo, M. R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.14.949784 · Cited by 8
Challenges in Drug Development for Neurological Disorders
Guha, L., Singh, N., & Kumar, H. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_2 · Cited by 12
Intermittent Access To Ethanol Induces Escalated Alcohol Consumption In Primates
Lindell, S. G., Schwandt, M. L., Suomi, S. J., Rice, K. C., Heilig, M. A., & Barr, C. S. (2017) · Journal of Addictive Behaviors Therapy & Rehabilitation · doi:10.4172/2324-9005.1000163 · Cited by 9
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Incentivizing Drug Development in Serious Mental Illness
Geils, H., Riley, A., & Lavelle, T. A. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.08.002 · Cited by 6
Developing algorithmic psychiatry via multi-level spanning computational models
Halassa, M. M., Frank, M. J., Garety, P. A., Öngür, D., Airan, R. D., Sanacora, G., Dzirasa, K., Suresh, S., Fitzpatrick, S. M., & Rothman, D. L. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102094 · Cited by 8
de Wall, G. V. (2023) · ALTEX · doi:10.14573/altex.2208261 · Cited by 6
Industry withdrawal from psychiatric medication development
Klein, D. F., & Glick, I. D. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2014-3603 · Cited by 6
Let's fail better: Using philosophical tools to improve neuroscientific research in psychiatry
Abalo‐Rodríguez, I., & Blithikioti, C. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16552 · Cited by 5
Modern Psychiatry: from Theory to Practice
Петрова, Н. Н. (2024) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2024-4-4-11-25 · Cited by 6
The Genetics-Driven Revival in Neuropsychiatric Drug Development
Gandal, M. J., & Geschwind, D. H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.024 · Cited by 6
Das, N. N., Srivastav, N., & Verma, S. S. (2021) · International Conference on Technological Advancements and Innovations (ICTAI) · doi:10.1109/ictai53825.2021.9673337 · Cited by 5
Emerging Selenium Nanoparticles for CNS Intervention
Malik, J. A., AjgarAnsari, J., Ahmed, S., Rani, A., Ansari, S. Y., & Anwar, S. (2023) · Biomedical engineering · doi:10.5772/intechopen.109418 · Cited by 11
Sawada, T., Feltrin, A. S., Wang, Y., Araújo, B. H. S., McCord, A. E., Giles, H. H., Han, S., Radulescu, E., Chen, Q., Qamar, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67154-0 · Cited by 5
HEINSSEN, R. K., Morris, S. E., & Sherrill, J. T. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae109 · Cited by 5
Characteristics of Trials Preceding FDA Approval of Novel Psychiatric Drugs
Ahn-Horst, R. Y., Turner, E. H., & Kesselheim, A. S. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.56588 · Cited by 4
Interventional Psychiatry in India: Bridging Treatment Gaps and Expanding Horizons in Mental Health
Joseph, J. T., & Praharaj, S. K. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176241294146 · Cited by 4
Litten, R. Z. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13222 · Cited by 4
Cardinale, E. M., Naim, R., Haller, S. P., German, R. E., Botz-Zapp, C. A., Bezek, J. L., Jangraw, D. C., & Brotman, M. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252245 · Cited by 4
Metadata
- Authors
- Hyman, S. E.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Hyman, Steven E.
- ORCID
- Hyman, Steven E.
- Venue
- Science Translational Medicine
- Published
- 2012-10-10
- Volume
- 4
- Issue
- 155
- Pages
- 155cm11-155cm11
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4250451153
- Cited by
- 260
- References
- 28
- Citations by year
- 2026: 17 · 2025: 10 · 2024: 20 · 2023: 13 · 2022: 19 · 2021: 24 · 2020: 16 · 2019: 25 · 2018: 19 · 2017: 15 · 2016: 22 · 2015: 25 · 2014: 16 · 2013: 16 · 2012: 3
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- drug discovery, mental illness, schizophrenia, bipolar disorder, depression, autism spectrum disorder, pharmaceutical industry, unmet medical needs
- MeSH terms
- Autistic Disorder, Bipolar Disorder, Pharmaceutical Preparations, Humans, Schizophrenia, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.